Blog

[printfriendly]
  • Mar 7, 2024

    Newly Funded Research: A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy

    Principal Investigator Shailly Jariwala, MS, PhD, of the Henry M. Jackson Foundation, was recently granted a Discovery Award totaling USD$319,151 for her research on a new therapy for peripheral neuropathy….
  • Feb 23, 2024

    Johnson & Johnson Joins Forces with the Foundation for Peripheral Neuropathy as 2024 Impact Partner

    The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador…
  • Feb 12, 2024

    How a PN patient maintains hope

    Meet Jeff K., an FPN supporter and volunteer, recent retiree, and resident of West Hartford, CT Jeff was diagnosed with peripheral neuropathy (PN) nine years ago, with noticeable issues emerging…
  • Feb 1, 2024

    Understanding the Connection Between Polyneuropathy and hATTR Amyloidosis

    “I have to be my own advocate, and you should be too,” said Christine, living with hereditary ATTR (hATTR) amyloidosis. “Once you know something, you can deal with it head-on….
  • Jan 18, 2024

    Clinical Research Training Scholarship Recipient Announced

    The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024 Clinical Research Training Scholarship (CRTS) recipient for peripheral neuropathy (PN), Francesco E. Michelassi, MD, Neuromuscular Research Fellow, Columbia…
  • Jan 11, 2024

    New PN Biobank Research Discovery!

    In November 2023, a new discovery was made about neuropathic pain in patients suffering from idiopathic peripheral neuropathy. Using data from the Peripheral Neuropathy Research Registry (PNRR), the Foundation for…
  • Jan 3, 2024

    FPN Funds IMAGiNe Study for anti-MAG Research

    Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000…
  • Nov 13, 2023

    FPN Welcomes Dr. David Bennett

    The Foundation for Peripheral Neuropathy (FPN) welcomes Dr. David Bennett, MB, PhD, to the Foundation’s Scientific Advisory Board (SAB), effective November 2023. The SAB advises both the Board of Directors…